missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18101137

TAZ/WWTR1 Antibody (OTI1H9), DyLight 405, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-74449V

Product Code. 18101137

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

TAZ/WWTR1 Monoclonal specifically detects TAZ/WWTR1 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TAZ/WWTR1
Monoclonal
DyLight 405
50mM Sodium Borate with 0.05% Sodium Azide
WWTR1
Full length recombinant protein of human TAZ/WWTR1 (NP_057287) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat
IgG2a
Western Blot, Immunohistochemistry
OTI1H9
Western Blot, Immunohistochemistry
FLJ27004, FLJ45718, TAZDKFZp586I1419, transcriptional co-activator with PDZ-binding motif, Transcriptional coactivator with PDZ-binding motif, WW domain containing transcription regulator 1, WW domain-containing transcription regulator protein 1
Mouse
Affinity Purified
Chromatin Research, Mesenchymal Stem Cell Markers, Signal Transduction, Stem Cell Markers, Transcription Factors and Regulators
25937.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.